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ABSTRACT
Background The prevalence of diabetes is increas-
ing with growing levels of obesity and an aging
population. New practical guidelines for diabetes
provide an applicable classiﬁcation. Inconsistent
coding of diabetes hampers the use of computerised
disease registers for quality improvement, and
limits the monitoring of disease trends.
Objective To develop a consensus set of codes that
should be used when recording diabetes diagnostic
data.
Methods The consensus approach was hierarchi-
cal, with a preference for diagnostic/disorder codes,
to deﬁne each type of diabetes and non-diabetic
hyperglycaemia, which were listed as being com-
pletely, partially or not readily mapped to available
codes. The practical classiﬁcation divides diabetes
into type 1 (T1DM), type 2 (T2DM), genetic, other,
unclassiﬁed and non-diabetic fasting hyperglycaemia.
We mapped the classiﬁcation to Read version 2,
Clinical Terms version 3 and SNOMED CT.
Results T1DM and T2DMwere completely mapped
to appropriate codes. However, in other areas only
partial mapping is possible. Genetics is a fast-
moving ﬁeld and there were considerable gaps in
the available labels for genetic conditions; what the
classiﬁcation calls ‘other’ the coding system labels
‘secondary’ diabetes. The biggest gap was the lack of
a code for diabetes where the type of diabetes was
uncertain. Notwithstanding these limitations we
were able to develop a consensus list.
Conclusions It is a challenge to develop codes that
readily map to contemporary clinical concepts.
However, clinicians should adopt the standard
recommended codes; and audit the quality of their
existing records.
Keywords: data quality, diabetes mellitus, medical
records systems computerised, records as topic,
vocabulary controlled, medical informatics
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Introduction
The estimated number of adults in England with
diabetes mellitus was 3.1 million in 2010 and is
predicted to rise to 4.6 million by 2030.1 The current
cost of treating diabetic complications is £7.7 billion,
which represents almost 80% of NHS diabetes spend-
ing, and this has been predicted to increase to £13.5
billion by 2035/6.2 Although estimates of the preva-
lence of diabetes and its complications vary, there is a
high burden of morbidity among the large and grow-
ing diabetic population from diabetic complications
which are potentially preventable by consistent appli-
cation of evidence-based guidelines.
England is in advance of many countries in devel-
oping systems to support physicians to improve the
quality of care they provide by applying evidence-
based guidelines. This is known as regulatory com-
pliance and has been underpinned by better use of
information systems.3 The components of regulatory
compliance, which also include the use of incentives
and inspection, can be represented formulaically (Figure
1). Clinical standards have beenmade explicit through
a series of National Service Frameworks and a Cancer
plan.4 A wider range of guidance is provided by the
National Institute for Health and Clinical Excellence
(NICE).5 Furthermore, pay for performance (P4P)
has been introduced into primary care to encourage
better conformance with and to accelerate the adop-
tion of evidence-based practice.6 The current UK
regulator ensuring compliance is the Care Quality
Commission (CQC).7 The measurement of perform-
ance is underpinned by information systems.8
Within diabetes, several components for achieving
regulatory compliance are in place:
. The National Service Framework identiﬁes up-to-
date explicit clinical standards.9
. Incentives for practices to run primary-care-based
diabetes clinics have been in place for several years;
larger practices may have been able to respond
better to them.10 P4P initially did not diﬀerentiate
types of diabetes. However, from 2006 separate P4P
indicators were created for patients with type 1
diabetes (T1DM) and type 2 (T2DM). The impact
of these incentives remains unclear.11
. Regulation and inspection have not really aﬀected
the delivery of diabetes care. The National Diabetes
Audit (NDA), although the largest and most com-
prehensive diabetes audit in the world, provides
only a light touch overview of the quality of care.
Although this audit work is due to be extended into
gestational diabetes and foot care in the coming
years.12
. UK general practice is comprehensively computer-
ised. Electronic clinical management systems, in
which the clinician selects codes to record consul-
tations directly into computerised medical record
(CMR) systems are widely used for case manage-
ment.13,14 Access to data for audit purposes will
improve with the implementation of a new com-
prehensive general practice (data) extraction service
(GPES) with the goal of conducting more national
quality improvement initiatives.15
All practices are required to compile a patient register
of patients with diabetes, and electronic case manage-
ment with clinician-led coding allows this to be auto-
mated. These patient registers are primarily used to
support the application of guidelines, for example, in
prompting appropriate routine screening for diabetic
complications. They can also be used for clinical audit
and quality improvement. Electronic data from pri-
mary care databases are also used to compile routine
data for monitoring of disease trends, and for epi-
demiological studies.16 These functions all rely on
clear and consistent classiﬁcation and coding of dia-
betes at the point of care.
In order to provide clarity the Royal College of
General Practitioners (RCGP) and NHS Diabetes set
up a Classiﬁcation of Diabetes working group, which
included a subgroup looking at the informatics issues
around the implementation of a new classiﬁcation.
The working group created a pragmatic classiﬁcation
for diabetes (Figure 2), yet made no speciﬁc recom-
mendations for coding. This paper sets out to ﬁll that
gap by recommending codes for the coding systems
most commonly used in UK primary care.
Method
Terminologies
Codes were identiﬁed for the two most commonly
used coding systems used in the UK: Read version 2,
(also described as ‘5-byte’ because it has ﬁve character
codes) and Read Clinical Terms version 3 (CTv3);
and also for systematised nomenclature of medicine
Figure 1 Components of regulatory compliance
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(SNOMED CT).17 Read codes are universally used in
UK primary care and also internationally, a four-
character version of Read codes is still used in New
Zealand,18 and elsewhere. SNOMED CT19 is increas-
ingly used internationally and is progressively being
introduced across the UK.20,21 SNOMED CT is much
more sophisticated than Read. It includes concept
identiﬁers (ID) which categorise each code; the equiv-
alent of the chapters in Read. Examples relevant to this
paper include a concept ID being a ‘disorder’, ‘situ-
ation’, ‘qualiﬁers’ and ‘ﬁndings’. In SNOMED CT
diabetes is a disorder; the concept ID that excludes
diabetes is a situation; and qualiﬁers are concept IDs
that explain other concepts, for example, suspecting a
condition. Impaired glucose tolerance in a lab test report
is a ﬁnding, however, there is also a separate concept
ID as a disorder. Also, a uniﬁed medical language
system (UMLS) facilitatesmapping of terms identiﬁed
within SNOMED CT into other coding systems.22
Consensus coding list
We have made these recommendations based on a
consensus process and selecting codes from logical
places within the coding system. For a hierarchical
system, like Read version 2, we included codes as high
up the hierarchy as possible, labelling codes which had
child codes which are valid with a percentage sign (%).
There are sometimes exceptions within the child codes,
and if so we ﬂag those that we recommend are not
used. For a polyhierarchical system, where codes are
linked in a matrix, it is not possible to use the
percentage sign in the same way, with linkage follow-
ing a diﬀerent set of rules and relationships.
Choice of codes
We generally suggest using diagnostic codes, i.e.
disorder concept IDs in SNOMED CT. It is possible
to infer someone has diabetes from disease monitoring,
administration or other codes.23 However, our as-
sertion is that it is better to use disease codes wherever
possible – from Chapter ‘C’ of the Read version 2
terminology. Chapter ‘C’ includes: endocrine, nutri-
tional, metabolic and immunity disorders. However,
these labels are arbitrary, for example the Inter-
national Classiﬁcation of Disease uses ‘Chapter E’ –
endocrine, nutritional and metabolic diseases. The
polyhierarchical CTv3 does not follow the same pat-
tern of codes, although many codes in CTv3 used in
diabetes and related conditions (e.g. impaired fasting
glucose) start X40. Within SNOMED CT we always
chose a ‘disorder’ code where available; using these
ahead of situation or ﬁnding classiﬁed concept IDs.
Code browsers
The Read codes were identiﬁed from NHS Clinical
Terminology Browser24 and SNOMED CT from the
SnoﬂakeTM Browser.25 The Terminology Brower is a
hierarchical display of codes and their child codes; the
Snoﬂake Browser combines a hierarchical list with a
visual display of linked parent and child concepts.
SNOMED CT terms are all mapped to SNOMED
RT (Reference Terminology) and CTv3 within the
Snoﬂake browser. However, we selected preferred
SNOMED CT terms independently.
Figure 2 RCGP and NHS diabetes practical classiﬁcation of diabetes
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Mapping the codes
By consensus we agreed whether a code was a ‘direct
mapping’, a ‘possible mapping’, or ‘no clear map-
ping’.26
Recommended code list for
diabetes
Coding diabetes
Type 1 and type 2 diabetes coding
recommendations
Using Read2 T1DM is straightforward; we suggest
using the C10E% hierarchy only. We recommend the
use of the C10F% for T2DM; and all its child codes
except two. The two child codes we recommend that
areNOTused areC10F8 andC10FS. C10F8 is the code
for ‘Reaven’s syndrome’ – an eponymous name for
metabolic syndrome. If practices use C10F8 for meta-
bolic syndrome then searches on C10F% will include
people who may not meet the diagnostic criteria for
T2DM. The ‘correct’ code for metabolic syndrome
belongs to the insulin resistance (C1A) hierarchy, and
we advise using C1A0 for this. In CTv3, X40J4 and
X40J5, and for SNOMED,CT 46635009 and 44054006
are the concept terms for T1DM and T2DM, respect-
ively.
Genetic diabetes
To some extent all diabetes has a genetic component
and this code is reserved for diabetes generally
associated with a single gene defect. There is no single
code that can be used for ‘genetic’ diabetes in Read 2,
but there is in CTv3 and SNOMED CT; the CTv3
generic term is ‘Genetic syndromes of diabetes
mellitus’ (X40JG) and the SNOMED CT concept ID
‘Diabetes associated with a genetic disorder’ (5969009).
One of the best known clinically described variants
is maturity onset diabetes of the young (MODY).
However, even this rare, but recognised condition
has a number of diﬀerent underlying genetic vari-
ants.27 One of these can be an autosomal-dominant
variant of type 2 diabetes, which has its own codes
(C10D in Read 2, X40JJ in CTv3 and 237604008 in
SNOMED CT).28 The Read coding system currently
has sections C10C% and C10D% assigned for genetic
causes of diabetes, whereas in CTv3 several of the
codes start X40... but again it will have many code
roots reﬂecting its polyhierarchical nature. SNOMED
CT concept IDs are dissimilar so there are no obvious
alphanumeric indications of where any particular
code lies in the hierarchy. The conceptual mapping
displayed in the Snoﬂake browser has the potential to
allow navigation around the coding system; however
it is not supported by suﬃcient concept IDs within
SNOMED CT. Unsurprisingly, the terms don’t neatly
meet developments in this fast-moving ﬁeld.
Other (or secondary) diabetes
This area of diabetes is relatively easy to code. There is
a generic code (C10N in Read 2, X40JA in CTv3 and
8801005 in SNOMED CT) and a range of other codes
to ﬁtwith knownother causes of diabetes. The concept
map in the Snoﬂake browser is particularly useful, in
displaying the 10 related concepts (Figure 3).
Unknown/unclassiﬁed
Where the diagnosis is uncertain, we suggest using the
suspected diabetes mellitus code (1JL... in Read 2 and
XaXPB in CTv3). In SNOMED CT there was no
speciﬁc concept ID for suspected diabetes, although
there were suspected disease codes for a range of other
conditions. There are concept IDs for suspected heart
disease, hypertension, etc. for 29 conditions, but not
diabetes. This situation can be coded ﬁrstly using the
SNOMED CT qualiﬁers ‘Known possibly present’
(410590009) or ‘Suspected’ (415684004).
Once the diagnosis is known, this can be superseded
by the correct code; if diabetes is ruled out we suggest
the diabetes mellitus excluded code (1I0... in Read 2,
XaFvt in CTV3 or 315216001 in SNOMED CT) is
used. Because computer systems assign dates to each
code it is not diﬃcult to identify the latest code to
deﬁne the diagnosis.
Non-diabetic hyperglycaemia
Impaired fasting glucose and impaired
glucose tolerance
These are established biochemical deﬁnitions based
on glucose levels in blood samples for the commonest
forms of non-diabetic hyperglycaemia; notwithstand-
ing that many CMR systems lack proper labelling of
whether tests are taken fasted or not.29 However, we
are entering a period of transition in which glycated
haemoglobin (HbA1c) may be used instead, which
will remove this problem.
. Impaired fasting glucose (IFG) is deﬁned as a fasting
glucose between 6.1 and 6.9 mmol/L. However, this
may be set to change with the move towards using
HbA1c to deﬁne IFG;30 although this remains open
to debate.31 There are two sets of units for HbA1c:
the Diabetes Control of Complication Trial (DCCT),
which is expressed as a percentage, is gradually
being superseded by the International Federation
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of Clinical Chemists (IFCC) units which are
expressed as mmol/mol.
. Impaired glucose tolerance (IGT) is deﬁned as
blood glucose between 7.8 and 11.1 mmol/L tested
2 hours after a 75-g glucose load. There have been
similarmoves towards usingHbA1c for diagnosis,32
but as yet there is no consensus.
There is no precise rubric for IFG in the Read codes.
The nearest is impaired fasting glycaemia (C11y3 in
Read 2, XaIRY in CTv3 and 390951007 in SNOMED
CT); there is a precise match for IGT (C11y2 in Read 2
and X40Jh in CTv3). There are alternatives oﬀered in
SNOMED CT for IGT, this can be coded as a disorder
(9414007) or as a ﬁnding (166927002). In keeping
with our general recommendations, we suggest using
the disorder code. Usefully, CTv3 and SNOMED CT
contain a speciﬁc code for IGT in pregnancy (X40JI
and 237625008, respectively). As so often in large
coding systems, there is another alternative for the
same codes. However, these alternative codes in Read
2 are in the ‘R’ chapter – ‘Symptoms, signs and ill-
deﬁned conditions’. We recommend using the ‘C’
chapter codes in Read 2; again there is greater com-
plexity in CTv3.
Our recommendation during this period of tran-
sition is that IFG and IGT codes are used with respect
to glucose results; but to make sure that all HbA1c
results are coded; where possible using IFCC results as
these units are likely to endure.
Gestational diabetes
The new practical classiﬁcation is clear about who has
gestational diabetes. To have a diagnosis of gestational
diabetes you must have diabetes only during the
pregnancy, and not before. Unfortunately, most of
the codes for gestational diabetes are contained in the
L180% hierarchy of the Read 2 codes, which is
described as diabetes mellitus during pregnancy,
childbirth and the puerperium, and does not exclude
previous diabetes. To avoid ambiguity, we suggest one
single code – L1808 Diabetes mellitus arising in
pregnancy; this same code is available in CTv3. This
emphasises that diabetes must have ‘arisen’ during
pregnancy. The SNOMEDCT equivalent is 11687002.
Summary tables for each terminology
Summary tables set out recommended codes for each
clinical system. They are also available on-line at:
http://www.clininf.eu/diabetes_codes (Tables 1–3).
Discussion
Principal ﬁndings
Although it is not possible to precisely map all the
clinical concepts in the practical classiﬁcation of
Figure 3 Screen shot of the SnoﬂakeTM browser showing the relationships with the concept secondary
diabetes mellitus (disorder)
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diabetes to concepts in any of the three terminologies,
it is possible to produce a workable list of clinical
codes. Some parts of the classiﬁcation are precisely
and readily mapped. These are T1DM and T2DM.
Gaps in other areas exist for diﬀerent reasons. The gap
in being able to code genetic types of diabetes appears
to be related to the rapid advances in that area. There is
an important semantic diﬀerence between the practi-
cal classiﬁcation, which uses ‘other’ types of diabetes
where the terminologies use ‘secondary’. The one
concept it is impossible to map with a very similar
meaning is the ‘unknown/unclassiﬁed’ type of dia-
betes in which the best match is to use ‘diabetes
suspected’ and if not conﬁrmed ‘use excluded’. For
non-diabetic hyperglycaemia, we recommend coding
HbA1c, or where appropriate glucose, and the value to
avoid confusion. The manual mapping achieved
through searching SNOMED CT and CTv3 browsers
separately revealed no diﬀerences in mapping.
Implication of the ﬁndings
It is possible to create a working limited list of codes
whichwill facilitate the identiﬁcation and follow-up of
people with diabetes. However, the data model in a
coding system does not match the disease classiﬁ-
cation developed by clinicians and compromises are
needed. Revision of the coding system could close this
gap. However, the downside of constant revision is
Table 1 Recommended code list and exclusions – Read version 2 (5-Byte) codes
RCGP/NHS Diabetes Classiﬁcation
Name Acronym Code Rubric
Type 1 T1DM C10E% Type 1 diabetes mellitus
Type 2 T2DM C10F% Type 2 diabetes mellitus
Genetic C10C. Diabetes mellitus autosomal dominant
Maturity onset DM in the
young
MODY C10C. Maturity-onset diabetes in youth (when
used with term code 11 or 12)
C10D. Diabetes mellitus autosomal dominant
type 2
C10FS Maternally inherited DM
Other
Generic C10N. Secondary diabetes mellitus
C10N1 Cystic-ﬁbrosis-related diabetes mellitus
Steroid induced C10B. Diabetes mellitus induced by steroids
C10H. Diabetes mellitus induced by non-steroid
drugs
C10G. Secondary pancreatic diabetes mellitus
Unknown
Suspected 1JL.. Suspected diabetes mellitus
When diagnosis excluded 1I0.. Use this code when diabetes excluded
Non-diabetic hyperglycaemia
Impaired glucose tolerance
and impaired fasting glucose
Impaired glucose tolerance IGT C11y2 Impaired glucose tolerance (IGT)
Glycated haemoglobin
deﬁned IGT
HbA1c
deﬁned IGT
42W5.
42W4.
IFCC Range 42–47 mmol/mol**
DCCT Range 6.0–6.49%**
Impaired fasting glucose IFG C11y3 Impaired fasting glycaemia (IFG)
Gestational diabetes
Gestational L1808 Diabetes mellitus arising in pregnancy
** Subject to conﬁrmation in NICE guidance.
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that the coding systems will have to carry forward the
previous diagnostic category labels, resulting in an
ever more complex range of coding alternatives.
Diﬀerent use of words in the clinical classiﬁcation
and the terminology, ‘other’ and ‘secondary’ respect-
ively in this case, create barriers to the ready searching
for codes from the natural language thatmight be used
by clinicians. Clinicians and informaticians need to be
sensitive to this and try to minimise these gaps. We
could have just looked forCTv3 terms by searching the
Snoﬂake browser and taking their mapping of CTv3
codes to SNOMED CT.
Table 2 Recommended code list for Clinical Terms version (CTv3)
RCGP/NHS Diabetes
Classiﬁcation of diabetes
category and sub-categories
Read code
Acronym Clinical
Terms version
3 (CTv3)
Rubric
RCGP/NHS Diabetes Classiﬁcation of diabetes
Type 1 T1DM X40J4 Type 1 diabetes mellitus
Type 2 T2DM X40J5 Type 2 diabetes mellitus
Genetic X40JG Genetic syndromes of diabetes mellitus
X40JI Diabetes mellitus autosomal dominant
Maturity-onset DM
in the young
MODY XSETH Maturity-onset diabetes in youth (when
used with term code 11, or 12)
X40JJ Diabetes mellitus autosomal-dominant
type 2
XaOPt Maternally inherited DM
Other
Generic X40JA Secondary diabetes mellitus
XaMzI Cystic-ﬁbrosis-related diabetes mellitus
XSETK Drug-induced diabetes mellitus
Steroid induced C11y0 Diabetes mellitus induced by steroids
XaJUI Diabetes mellitus induced by non-steroid
drugs
X40JB Secondary pancreatic diabetes mellitus
Unknown
Suspected XaXPB Suspected diabetes mellitus
When diagnosis excluded XaFvt Use this code when diabetes excluded
Non-diabetic hyperglycaemia
Impaired glucose tolerance
and impaired fasting glucose
Impaired glucose tolerance IGT X40Jh Impaired glucose tolerance
X40JI Impaired glucose tolerance in pregnancy
Glycated haemoglobin
deﬁned IGT
HbA1c
deﬁned IGT
XaPbt
XaERp
IFCC Range 42–47 mmol/mol**
DCCT Range 6.0–6.49%**
Impaired fasting glucose IFG XaIRY Impaired fasting glycaemia
Gestational diabetes
Gestational GDM L1808 Diabetes mellitus arising in pregnancy
** Subject to conﬁrmation in NICE guidance.
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Table 3 Recommended code list for Systematised Nomenclature of Medicine Clinical Terms
(SNOMED CT)
RCGP/NHS Diabetes
Classiﬁcation of Diabetes
category and sub-categories
SNOMED CT
Acronym Concept ID Rubric
‘‘DM’’ = Diabetes mellitus
The full name is used in the rubric in the
Snoﬂake browser
RCGP/NHS Diabetes Classiﬁcation of diabetes
Type 1 T1DM 46635009 Diabetes mellitus type 1
Type 2 T2DM 44054006 Diabetes mellitus type 2
Genetic 5969009 DM associated with genetic syndrome
(disorder)
Maturity onset DM in the
young
MODY 28453007 Maturity onset diabetes in the young
(disorder)
237604008 Diabetes mellitus autosomal-dominant
type 2 (disorder)
237619009 Diabetes-deafness maternally transmitted
(disorder)*
Other
Generic 8801005 Secondary diabetes mellitus (disorder)
426705001 DM associated with cystic ﬁbrosis
(disorder)
5368009 Drug-induced diabetes mellitus (disorder)
Steroid induced 190447002 Steroid-induced diabetes (disorder)
408540003 DM induced by non-steroid drugs
(disorder)
51002006 Diabetes mellitus with pancreatic disease
(disorder)
Unknown
Suspected 415684004 Suspected (qualiﬁer term)
When diagnosis excluded 315216001 Diabetes excluded (situation)
Non-diabetic hyperglycaemia
Impaired glucose tolerance
and impaired fasting glucose
Impaired glucose tolerance IGT 9414007 Impaired glucose tolerance (disorder)
237628005 Impaired glucose tolerance in pregnancy
(disorder)
Glycated haemoglobin
deﬁned IGT
HbA1c
deﬁned IGT 313835008
IFCC Range 42–47 mmol/mol**
DCCT Range 6.0–6.49%**
Impaired fasting glucose IFG 390951007 Impaired fasting glycaemia (disorder)
Gestational diabetes
Gestational GDM 11687002 Gestational diabetes mellitus (disorder)
*Nearest match. ** Subject to conﬁrmation in NICE guidance.
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Comparison with the literature
Despite the diﬃculties of working with coded data, it
is probably a better alternative thanworking with free-
text.33 Gaps between coding systems and clinical
concepts have been recognised for some time. Possibly
longest in use is the International Classiﬁcation of
Disease (ICD) where it is recognised that often more
than one code is needed to describe a clinical con-
dition. The convention that has come about there is
the use of the ‘dagger and asterisk’. A dagger is applied
to the primary diagnosis, with asterisks applied to the
secondary, but also necessary, labels.34
Coding systems carry forward legacy codes and how
a lack of coding results in failure to identify cases of
diabetes. There is considerable misclassiﬁcation, mis-
coding and misdiagnosis of diabetes.35–37 An expert
reported disappointment that legacy codes such as
‘Insulin-dependent diabetes mellitus, IDDM’, are still
used; a classiﬁcation superseded by the division into
T1DM and T2DM.38 A cross-sectional survey of 3.6
million patients’ electronic records found that around
1% of the UK populationmay have diabetes (based on
glucose blood test results) that is not recorded on
practice registers,1 and diabetes prevalence estimates
based on Health Survey for England HbA1c measure-
ments in 2006 suggested that up to 27% of diabetics
were undiagnosed or missing from practice registers.3
Variable use of complex coding systems may account
for some of these missing patients, who may be less
likely to receive well-organised care as a result. Map-
ping between systems has challenges,39 though the
automated linkage created within the Snoﬂake browser
appeared reliable.
Coding is not just a primary care issue. Whilst
people with diabetes have longer lengths of stay in
hospital, and are more likely to be readmitted,40 there
are also problems of poor coding in hospital.41
Limitations
We could not create completely clear and unambigu-
ous mapping between the practical classiﬁcation and
any of the classiﬁcation systems. The limitations of the
study include the relatively small group who agreed
the clinical codes, and although we know that people
who are not coded correctly receive inappropriate or a
lower standard of care,42 we lack direct evidence that
improving quality aﬀects outcomes for patients. Whilst
we know that there is a problem with coding, we lack
the evidence that putting this right will substantially
improve care.
Conclusions
The higher the quality of clinical coding the easier it
will be to ensure that individual patients receive the
best care and that we can audit the quality of care and
use primary care data in monitoring disease trends.
The proposed mapping has limitations but is feasible
to apply in clinical practice. The suggested codes should
facilitate the consistent coding of diabetes in clinical
records.
Recommendations
. Prospectively use the appropriate coding list.
1 In the UK Read version 2 for EMIS, in-practice
systems (INPS), and iSoft brands of CMR sys-
tems); and Read Clinical Terms version 3 (for
TPP SystmOne) are available at http://www.
clininf.eu/diabetes_codes
2 The SNOMED CT table of codes could be
applied in countries using that nomenclature
and be mapped to other coding systems.
. Critically appraise how people with diabetes are
classiﬁed and coded in your CMR each time they
attend practice diabetes clinics.
. In the UK run the audit tools available at
www.clininf.eu/diabetes.html to identify miscoded,
misclassiﬁed and misdiagnosed people with dia-
betes. These can be replicated for use in other health
systems.
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